A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -54.79% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -38.51%. Over the past 30 days, the price of OGN has leaped by -4.08%. And in the last five days, it has fallen by -2.83%.
The stock of Organon & Co (OGN) is currently priced at $9.63. In the last session, the stock climbed significantly, topping out at $18.0 after opening at $9.63. The day’s lowest price was $10.0 before the stock closed at $9.56.
Organon & Co ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $23.10 on 08/26/24, while the lowest value for the same period was recorded at $8.01 on 05/14/25.
52-week price history of OGN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Organon & Co’s current trading price is -58.31% away from its 52-week high, while its distance from the 52-week low is 20.22%. The stock’s price range during this period has varied between$8.01 and $23.10. The Organon & Co’s shares, which operate in the Healthcare, saw a trading volume of around 3.36 million for the day, a figure considerably lower than their average daily volume of 5.65 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Organon & Co (OGN) has experienced a quarterly decline of -14.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.50B and boasts a workforce of 10000 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.57, with a change in price of -6.06. Similarly, Organon & Co recorded 5,032,429 in trading volume during the last 100 days, posting a change of -38.62%.
OGN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OGN stands at 16.52. Similarly, the long-term debt-to-equity ratio is also 16.49.
OGN Stock Stochastic Average
Organon & Co’s raw stochastic average for the past 50 days is presently 66.67%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 18.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 21.89% and 34.01%, respectively.
